{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:18:00Z","timestamp":1783606680032,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Health, Czech Republic","award":["00064203"],"award-info":[{"award-number":["00064203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12223-019-00752-w","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T23:20:04Z","timestamp":1572045604000},"page":"475-482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vancomycin and its crystalline degradation products released from bone grafts and different types of bone cement"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-5662","authenticated-orcid":false,"given":"Eva","family":"Klapkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Nescakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Melichercik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jahoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1788-9788","authenticated-orcid":false,"given":"Katerina","family":"Dunovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Cepova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6408-7086","authenticated-orcid":false,"given":"Richard","family":"Prusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/538061","volume":"2012","author":"K Anagnostakos","year":"2012","unstructured":"Anagnostakos K, Schr\u00f6der K (2012) Antibiotic-impregnated bone frafts in orthopaedic and trauma surgery: a systematic review of the literature. Int J Biomater 2012:1\u20139","journal-title":"Int J Biomater"},{"issue":"8","key":"752_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0731-7085(97)00140-4","volume":"16","author":"DW Backes","year":"1998","unstructured":"Backes DW, Aboleneen HI, Simpson JA (1998) Quantitation of vancomycin ant its crystalline degradation products (CDP-1) in human serum by high performance liquid chromatography. J Pharm Biomed Anal 16(8):1281\u20131287","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"752_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1128\/AAC.33.6.791","volume":"33","author":"RE Brummett","year":"1989","unstructured":"Brummett RE, Fox KE (1989) Vancomycin and erythromycin inducted hearing loss in humans. Antimicrob Agents Chemother 33(6):791\u2013796","journal-title":"Antimicrob Agents Chemother"},{"key":"752_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/00016470510030797","volume":"76","author":"M Buttaro","year":"2005","unstructured":"Buttaro M, Gimenez MI, Greco G, Barcan L, Piccaluga F (2005a) High active local levels of vancomycin without nephrotoxicity released from impacted bone allograft in 20 revision hip arthroplasties. Acta Orthop 76:336\u2013340","journal-title":"Acta Orthop"},{"issue":"3","key":"752_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1302\/0301-620X.87B3.14788","volume":"87","author":"M Buttaro","year":"2005","unstructured":"Buttaro M, Pusso R, Piccaluga F (2005b) Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. J Bone Joint Surg (Br) 87(3):314\u2013319","journal-title":"J Bone Joint Surg (Br)"},{"key":"752_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2106\/00004623-200704000-00026","volume":"89","author":"Q Cui","year":"2007","unstructured":"Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ (2007) Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am 89:871\u2013882","journal-title":"J Bone Joint Surg Am"},{"key":"752_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1365\/s10337-004-0489-0","volume":"61","author":"A Ghassempour","year":"2005","unstructured":"Ghassempour A, Abdollahpour A, Tabar-Heydar K, Nabid MR, Mansouri S, Aboul-Enein HY (2005) Crystalline degradation products of vancomycin as a new clinical stationary phase for liquid chromatography. Chromatographia 61:151\u2013155","journal-title":"Chromatographia"},{"issue":"3","key":"752_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0883-5403(99)90061-X","volume":"14","author":"J Klekamp","year":"1999","unstructured":"Klekamp J, Dawson J, Haas DW, DeBoer D, Christie M (1999) The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effect and elution kinetics for use in joint arthroplasty. J Arthroplast 14(3):339\u2013346","journal-title":"J Arthroplast"},{"key":"752_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ocl.2004.06.010","volume":"36","author":"KD Kuehn","year":"2005","unstructured":"Kuehn KD, Ege W, Gopp U (2005) Acrylic bone cements: composition and properties. Orthop Clin North Am 36:17\u201328","journal-title":"Orthop Clin North Am"},{"key":"752_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0883-5403(98)90179-6","volume":"13","author":"BA Masri","year":"1998","unstructured":"Masri BA, Duncan CP, Beauchamp CP (1998) Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplast 13:331\u2013338","journal-title":"J Arthroplast"},{"key":"752_CR11","doi-asserted-by":"crossref","unstructured":"Meani E, Romano C, Crosby L, Hofmann G (2007) Infection and local treatment in orthopedic surgery. Springer","DOI":"10.1007\/978-3-540-47999-4"},{"issue":"5","key":"752_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12223-011-0093-2","volume":"57","author":"P Melicher\u010d\u00edk","year":"2012","unstructured":"Melicher\u010d\u00edk P, Jahoda D, Ny\u010d O, Klapkov\u00e1 E, Bart\u00e1k V, Landor I et al (2012) Bone grafts as a vancomycin carrier for local therapy of resistant infections. Folia Microbiol 57(5):459\u2013462","journal-title":"Folia Microbiol"},{"issue":"12","key":"752_CR13","first-page":"796","volume":"115","author":"P Melichercik","year":"2014","unstructured":"Melichercik P, Klapkova E, Landor I, Judl T, Sibek M, Jahoda D (2014) The effect of vancomycin degradation products in the topical treatment of osteomyelitis. Bratisl Lek Listy 115(12):796\u2013799","journal-title":"Bratisl Lek Listy"},{"key":"752_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005131-199505000-00007","volume":"9","author":"T Miclau","year":"1995","unstructured":"Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE (1995) Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9:401\u2013406","journal-title":"J Orthop Trauma"},{"key":"752_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00003086-199211000-00042","volume":"284","author":"CL Nelson","year":"1992","unstructured":"Nelson CL, Griffin FM, Harrison BH, Cooper RE (1992) In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop Relat Res 284:303\u2013309","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"752_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/00016470310018180","volume":"74","author":"D Neut","year":"2003","unstructured":"Neut D, van de Belt H, van Horn JR, van der Mei HC, Busscher HJ (2003) The effect of mixing on gentamicin release from polymethylmethacrylate bone cements. Acta Orthop Scand 74(6):670\u2013676","journal-title":"Acta Orthop Scand"},{"key":"752_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00003086-198801000-00029","volume":"226","author":"CR Perry","year":"1988","unstructured":"Perry CR, Davenport K, Vossen MK (1988) Local delivery of antibiotics via an implantable pump in the treatment of osteomyelitis. Clin Orthop Relat Res 226:222\u2013230","journal-title":"Clin Orthop Relat Res"},{"key":"752_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/491712","volume":"42","author":"MJ Rybak","year":"2006","unstructured":"Rybak MJ (2006) The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis 42:35\u201339","journal-title":"Clin Infect Dis"},{"issue":"3","key":"752_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M et al (2009) Vancomycin therapeutic guidelines: a summary of consensuses commendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacistsp. Clin Infect Dis 49(3):325\u2013327","journal-title":"Clin Infect Dis"},{"issue":"3","key":"752_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02936586","volume":"5","author":"AP Sattur","year":"2000","unstructured":"Sattur AP, Lee JH, Song KB, Panda T, Kim CH, Rhee SK et al (2000) Analytical techniques for vancomycin \u2013 a review. Biotechnol Bioprocess Eng 5(3):153\u2013158","journal-title":"Biotechnol Bioprocess Eng"},{"key":"752_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005131-199212000-00001","volume":"6","author":"D Seligson","year":"1992","unstructured":"Seligson D, Metha S, Voos K, Henry SL, Johnson JR (1992) The use of antibiotic-impregnated polymethylmethacrylate beads to prevent the evolution of localized infection. J Orthop Trauma 6:401\u2013406","journal-title":"J Orthop Trauma"},{"key":"752_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1592\/phco.19.9.702.31548","volume":"19","author":"AL Somerville","year":"1999","unstructured":"Somerville AL, Wright DH, Rotschafer JC (1999) Implication of vancomycin degradation products on therapeutic drug monitoring in patients with end-stage renal disease. Pharmacotherapy 19:702\u2013707","journal-title":"Pharmacotherapy"},{"key":"752_CR23","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0022-3549(15)00175-6","volume":"105","author":"T Such\u00fd","year":"2016","unstructured":"Such\u00fd T, \u0160upov\u00e1 M, Klapkov\u00e1 E, Horn\u00fd L, R\u00fdglov\u00e1 \u0160, \u017daloudkov\u00e1 M et al (2016) The sustainable release of vancomycin and its degradation products from nanostructured collagen\/hydroxyapatite composite layers. J Pharm Sci 105:1288\u20131294","journal-title":"J Pharm Sci"},{"key":"752_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/17453678008990768","volume":"51","author":"H Wahling","year":"1980","unstructured":"Wahling H, Dingeldein E (1980) Antibiotics and bone cements. Acta Orthop Scand 51:49\u201356","journal-title":"Acta Orthop Scand"},{"key":"752_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/jac\/46.3.423","volume":"46","author":"H Winkler","year":"2000","unstructured":"Winkler H, Janata O, Berger C, Wein W, Georgopoulos A (2000) In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother 46:423\u2013428","journal-title":"J Antimicrob Chemother"},{"key":"752_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1302\/0301-620X.90B12.20742","volume":"90","author":"H Winkler","year":"2008","unstructured":"Winkler H, Stobier A, Kaudela K, Winter F, Menschik F (2008) One stage uncemented revisison of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg (Br) 90:1580\u20131584","journal-title":"J Bone Joint Surg (Br)"},{"key":"752_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/00016470052943955","volume":"71","author":"E Witso","year":"2000","unstructured":"Witso E, Persen L, Loseth K, Benum P, Bergh K (2000) Cancellous bone as an antibiotic carrier. Acta Orthop Scand 71:80\u201384","journal-title":"Acta Orthop Scand"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-019-00752-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12223-019-00752-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-019-00752-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T18:15:31Z","timestamp":1664734531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12223-019-00752-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s12223-019-00752-w","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"30 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted according to the guidelines laid down in the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}